Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation

Annals of Thoracic Surgery

Volumn 81, Issue 2, 2006, Pages 619-624

  Day, Jonathan R S ^a   Haskard, Dorian O ^a   Taylor, Kenneth M ^a   Landis, Robert C ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; ARGININE 15; ARGININE 15 ALANINE 17; PEPTIDE; PHENYLALANYLLEUCYLLEUCYLARGINYLASPARAGINAMIDE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; RECOMBINANT PROTEIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; UNCLASSIFIED DRUG; VALINE 15 LEUCINE 17;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN MODIFICATION; THROMBOCYTE AGGREGATION INHIBITION;

APROTININ; CARDIOPULMONARY BYPASS; HUMANS; PLATELET AGGREGATION; RECEPTOR, PAR-1; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS;

EID: 31044450457     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.07.056     Document Type: Article

References (30)

1. B.J. Hunt, R.N. Parratt, H.C. Segal, S. Sheikh, P. Kallis, M. Yacoub Activation of coagulation and fibrinolysis during cardiothoracic operations Ann Thorac Surg 65 1998 712 718
2. M.D. Boisclair, D.A. Lane, H. Philippou, S. Sheikh, B. Hunt Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2 Thromb Haemost 70 1993 253 258
3. S.J. Brister, F.A. Ofosu, M.R. Buchanan Thrombin generation during cardiac surgery is heparin the ideal anticoagulant? Thromb Haemost 70 1993 259 262
4. V.A. Ferraris, S.P. Ferraris, A. Singh The platelet thrombin receptor and postoperative bleeding Ann Thorac Surg 65 1998 352 358
5. T.K. Vu, D.T. Hung, V.I. Wheaton, S.R. Coughlin Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation Cell 64 1991 1057 1068
6. M.L. Kahn, M. Nakanishi-Matsui, M.J. Shapiro, H. Ishihara, S.R. Coughlin Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin J Clin Invest 103 1999 879 887
7. D. Royston, B.P. Bidstrup, K.M. Taylor, R.N. Sapsford Effect of aprotinin on need for blood transfusion after repeat open heart-surgery Lancet 2 1987 1289 1292
8. W. van Oeveren, N.J. Jansen, B.P. Bidstrup Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass Ann Thorac Surg 44 1987 640 645
9. A. Berghoff von, U. Glatzel Inhibition of the fibrinolytic potential by Trasylol Med Klin 12 1963 476
10. E.R. Wildevuur, L. Eijsman, K.J. Roozendaal, M.P. Harder, M. Chang, W. van Oeveren Platelet preservation during cardiopulmonary bypass with aprotinin Eur J Cardiothorac Surg 3 1989 533 537
11. W. van Oeveren, M.P. Harder, K.J. Roozendaal, L. Eijsman, C.R. Wildevuur Aprotinin protects platelets against the initial effect of cardiopulmonary bypass J Thorac Cardiovasc Surg 99 1990 788 796
12. H. Nagaoka, R. Innami, F. Murayama Effects of aprotinin on prostaglandin metabolism and platelet function in open heart surgery J Cardiovasc Surg (Torino) 32 1991 31 37
13. G.E. Hill, A. Alonso, J.R. Spurzem, A.H. Stammers, R.A. Robbins Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans J Thorac Cardiovasc Surg 110 1995 1658 1662
14. Y.T. Wachtfogel, U. Kucich, C.E. Hack Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion J Thorac Cardiovasc Surg 106 1993 1 9
15. J.P. Gott, W.A. Cooper, F.E. Schmidt Jr Modifying risk for extracorporeal circulation trial of four antiinflammatory strategies Ann Thorac Surg 66 1998 747 753
16. J.M. Murkin, J. Maurer, S. Niemcryk Full dose aprotinin administration is associated with a significant decrease in perioperative stroke in patients undergoing elective cardiac surgery a meta-analysis Ann Thorac Surg 73 Suppl 2002 374
17. A. Sedrakyan, T. Treasure, J.A. Elefteriades Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery a systematic review and meta-analysis of randomized clinical trials J Thorac Cardiovasc Surg 128 2004 442 448
18. J.H. Levy, R. Pifarre, H.V. Schaff A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting Circulation 92 1995 2236 2244
19. M. Poullis, R. Manning, M. Laffan, D.O. Haskard, K.M. Taylor, R.C. Landis The antithrombotic effect of aprotinin actions mediated via the proteaseactivated receptor 1 J Thorac Cardiovasc Surg 120 2000 370 378
20. J.R. Day, P.P. Punjabi, A.M. Randi, D.O. Haskard, R.C. Landis, K.M. Taylor Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery Circulation 110 2004 2597 2600
21. T.A. Khan, C. Bianchi, P. Voisine, J. Sandmeyer, J. Feng, F.W. Sellke Aprotinin inhibits protease-dependent platelet aggregation and thrombosis Ann Thorac Surg 79 2005 1545 1550
22. K.N. Maquelin, R. Nieuwland, E.G. Lentjes ATS administration in the pericardial cavity does not prevent platelet activation J Thorac Cardiovasc Surg 120 2000 552 557
23. R.C. Landis, D.O. Haskard, K.M. Taylor New antiinflammatory and platelet-preserving effects of aprotinin Ann Thorac Surg 72 Suppl 2001 1808 1813
24. P.P. Liberski Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease a risk analysis Folia Neuropathol 38 2000 143 150
25. G.E. Hubner, R.C. Koch, K.B. Sprenger, P.J. Stadler, C.F. Golker Examination of the biological safety of a drug derived from mammalian organs Arzneimittelforschung 46 1996 657 661
26. E.A. Auerswald, D. Horlein, G. Reinhardt, W. Schroder, E. Schnabel Expression, isolation and characterization of recombinant [Arg15,Glu52]aprotinin Biol Chem Hoppe Seyler 369 Suppl 1988 27 35
27. J.R. Day, I.S. Malik, A. Weerasinghe Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation implications for restenosis during percutaneous coronary intervention Heart 90 2004 794 799
28. D. Pintigny, J. Dachary-Prigent Aprotinin can inhibit the proteolytic activity of thrombin. A fluorescence and an enzymatic study Eur J Biochem 207 1992 89 95
29. C.E. Junge, T. Sugawara, G. Mannaioni The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia Proc Natl Acad Sci USA 100 2003 13019 13024
30. K. Jurk, U.R. Jahn, H. Van Aken Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1) Thromb Haemost 91 2004 334 344